여성화유방 수술 시장 규모, 점유율, 동향 분석 보고서 : 연령대별, 수술 유형별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Gynecomastia Procedures Market Growth & Trends

The global gynecomastia procedures market size is expected to reach USD 1.58 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.8% from 2023 to 2030. The increasing awareness about gynecomastia, changing lifestyles such as sedentary habits, poor diet, hormonal imbalances, and the use of certain medications such as anabolic steroids, and antidepressants are the prime factors that drive the market growth.

Furthermore, advanced minimally invasive procedure approaches such as liposuction and glandular tissue excision have expanded treatment options for gynecomastia. These advancements have improved patient outcomes and satisfaction, further driving market growth. In addition, minimally invasive techniques have gained popularity in gynecomastia treatment as this treatment offers less invasive procedures, reduced scarring, faster recovery times, and improved cosmetic outcomes.

Advanced liposuction techniques, such as power-assisted liposuction (PAL) or ultrasound-assisted liposuction (UAL), have enhanced precision and improved results. Laser-assisted liposuction, such as Smartlipo or VASERlipo, utilizes laser or ultrasound energy to liquefy fat cells before removal. This technique can help tighten the skin and improve overall contour.

COVID-19 had a large impact on the market for gynecomastia. The procedure volume witnessed a significant decrease during the pandemic as gynecomastia is a minimally invasive treatment and the majority of the cosmetic clinics put a halt on such treatments. However, the market regained revenue post-pandemic. During the peak of the pandemic, the healthcare industry drastically adopted a more digital approach to minimize in-person visits and reduce the risk of transmission. This allowed patients to discuss their concerns remotely, including gynecomastia-related issues, and receive guidance or recommendations from healthcare professionals.

Gynecomastia Procedures Market Report Highlights

• In 2022, North America dominated the market with a 34.5% revenue share. The growth of the market in this region is increasing due to the affordability of healthcare services and the relatively higher disposable incomes of individuals in the region
• Based on age group, the above 40 age group segment dominated with the largest revenue share of 61.0% in 2022.This can be attributed to factors such as hormonal changes, and cumulative effects of risk factors over time are greater in older individuals
• Based on procedure type, the excision segment accounted for the largest revenue share of 54.3% due to its wide indications
• In terms of end-use, cosmetic surgery centers dominate the market with the largest revenue share of 63.8% in 2022, due to their expertise in various aesthetic procedures

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Market Definitions
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. Porter's Five Forces Analysis
• 3.5. COVID-19 Impact Analysis

Chapter 4. Age Group Business Analysis

• 4.1. Gynecomastia Procedures Market: Age Group Movement Analysis, 2022 & 2030
• 4.2. 18-40
  • 4.2.1. 18-40 Market, 2018 - 2030 (USD Million)
• 4.3. Above 40
  • 4.3.1. Above 40 Market, 2018 - 2030 (USD Million)

Chapter 5. Procedure Type Business Analysis

• 5.1. Gynecomastia Procedures Market: Procedure Type Movement Analysis, 2022 & 2030
• 5.2. Liposuction
  • 5.2.1. Liposuction Market, 2018 - 2030 (USD Million)
• 5.3. Excision
  • 5.3.1. Excision Market, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

• 6.1. Gynecomastia Procedures Market: End-Use Movement Analysis, 2022 & 2030
• 6.2. Hospitals
  • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.3. Cosmetic Surgery Center
  • 6.3.1. Cosmetic Surgery Center Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Regional Market Snapshot
• 7.2. North America
  • 7.2.1. North America Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
  • 7.2.2. The U.S.
    • 7.2.2.1. U.S. Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.2.2.2. Key Country Dynamics
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. Competitive Scenario
  • 7.2.3. Canada
    • 7.2.3.1. Canada Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.2.3.2. Key Country Dynamics
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Competitive Scenario
• 7.3. Europe
  • 7.3.1. Europe Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
  • 7.3.2. Germany
    • 7.3.2.1. Germany Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.2.2. Key Country Dynamics
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. Competitive Scenario
  • 7.3.3. UK
    • 7.3.3.1. UK Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.3.2. Key Country Dynamics
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Competitive Scenario
  • 7.3.4. France
    • 7.3.4.1. France Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.4.2. Key Country Dynamics
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Competitive Scenario
  • 7.3.5. Italy
    • 7.3.5.1. Italy Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.5.2. Key Country Dynamics
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Competitive Scenario
  • 7.3.6. Spain
    • 7.3.6.1. Spain Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.6.2. Key Country Dynamics
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Competitive Scenario
  • 7.3.7. Denmark
    • 7.3.7.1. Denmark Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.7.2. Key Country Dynamics
    • 7.3.7.3. Regulatory Framework
    • 7.3.7.4. Competitive Scenario
  • 7.3.8. Sweden
    • 7.3.8.1. Sweden Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.8.2. Key Country Dynamics
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Competitive Scenario
  • 7.3.9. Norway
    • 7.3.9.1. Norway Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.3.9.2. Key Country Dynamics
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Competitive Scenario
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Japan Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.4.2.2. Key Country Dynamics
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Competitive Scenario
  • 7.4.3. China
    • 7.4.3.1. China Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.4.3.2. Key Country Dynamics
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Competitive Scenario
  • 7.4.4. India
    • 7.4.4.1. India Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.4.4.2. Key Country Dynamics
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Competitive Scenario
  • 7.4.5. South Korea
    • 7.4.5.1. South Korea Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.4.5.2. Key Country Dynamics
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Competitive Scenario
  • 7.4.6. Australia
    • 7.4.6.1. Australia Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.4.6.2. Key Country Dynamics
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Competitive Scenario
  • 7.4.7. Thailand
    • 7.4.7.1. Thailand Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.4.7.2. Key Country Dynamics
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Competitive Scenario
• 7.5. Latin America
  • 7.5.1. Latin America Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
  • 7.5.2. Key Country Dynamics
  • 7.5.3. Regulatory Framework
  • 7.5.4. Competitive Scenario
  • 7.5.5. Brazil
    • 7.5.5.1. Brazil Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.5.5.2. Key Country Dynamics
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Competitive Scenario
  • 7.5.6. Mexico
    • 7.5.6.1. Mexico Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.5.6.2. Key Country Dynamics
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Competitive Scenario
  • 7.5.7. Argentina
    • 7.5.7.1. Argentina Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.5.7.2. Key Country Dynamics
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Competitive Scenario
• 7.6. MEA
  • 7.6.1. MEA Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. South Africa Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.6.2.2. Key Country Dynamics
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Competitive Scenario
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Saudi Arabia Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.6.3.2. Key Country Dynamics
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Competitive Scenario
  • 7.6.4. UAE
    • 7.6.4.1. UAE Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.6.4.2. Key Country Dynamics
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Competitive Scenario
  • 7.6.5. Kuwait
    • 7.6.5.1. Kuwait Gynecomastia Procedures Market, 2018 - 2030 (USD Million)
    • 7.6.5.2. Key Country Dynamics
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Competitive Scenario

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
  • 8.2.1. Acquisition
  • 8.2.2. Collaborations
  • 8.2.3. New Platform Launches
  • 8.2.4. Others
• 8.3. Company Profiles/Listing
  • 8.3.1. Cadila Pharmaceuticals Ltd
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Platform Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Sun Pharmaceuticals Industries Ltd
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Platform Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Zydus Cadila Healthcare Ltd
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Platform Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Biochem Pharmaceutical Industries Ltd
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Platform Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Dr. Reddy's Laboratories Ltd
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Platform Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Micro Nova Pharmaceuticals Ltd
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Platform Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Kee Pharma Ltd
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Platform Benchmarking
    • 8.3.7.4. Strategic Initiatives